Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters











Publication year range
1.
Mol Cell Endocrinol ; 503: 110698, 2020 03 01.
Article in English | MEDLINE | ID: mdl-31891770

ABSTRACT

Endocrine-disrupting chemicals (EDCs), such as perfluorooctanoate, perfluorooctane sulfonate, 2,2-dichlorodiphenyldichloroethylene, hexachlorobenzene, and polychlorinated biphenyl 153 are persistent pollutants that are found in human follicular fluid (FF). These compounds may affect endocrine function, disrupt steroid secretion by granulosa cells, and play a role in granulosa cell tumor (GCT) development. GCTs demonstrate endocrine activity, expressing aromatase and secreting 17ß-estradiol (E2). We aimed to determine the effects of a mixture of EDCs, similar to that found in human FF, on human granulosa tumor cell lines representing the juvenile (JGCT) and adult (AGCT) forms (COV434 and KGN cells, respectively). We found that all the individual compounds and mixtures tested altered granulosa tumor cell function by disrupting E2 secretion. In KGN cells, which possess significantly higher basal aromatase gene expression, and therefore secrete more E2 than JGCT cells, EDC mixtures activated estrogen receptors (ERs) and G protein-coupled receptor-30 signaling, thereby stimulating E2 secretion, without affecting aromatase expression. By contrast, in COV434 cells, which demonstrate higher CYP1A1 expression, a key mediator of estrogen metabolism, than KGN cells, EDC mixtures reduced E2 secretion in parallel with increases in the 2-hydroxyestrogen 1/E2 ratio and CYP1A1 expression, implying an upregulation of E2 metabolism. These results indicate that the EDC mixture present in FF disrupts E2 secretion in JGCT and AGCT cells according to the estrogen metabolic potential of the cell type, involving both classical and non-classical ER pathways.


Subject(s)
Endocrine Disruptors/pharmacology , Estradiol/metabolism , Estrogens/metabolism , Granulosa Cell Tumor/metabolism , Persistent Organic Pollutants/pharmacology , Cell Line, Tumor , Endocrine Disruptors/isolation & purification , Female , Follicular Fluid/chemistry , Granulosa Cell Tumor/pathology , Granulosa Cells/drug effects , Granulosa Cells/metabolism , Granulosa Cells/pathology , Humans , Metabolic Networks and Pathways/drug effects , Ovarian Neoplasms/metabolism , Ovarian Neoplasms/pathology , Secretory Pathway/drug effects
2.
Toxicol In Vitro ; 65: 104769, 2020 Jun.
Article in English | MEDLINE | ID: mdl-31923581

ABSTRACT

Insulin-like growth factor-1 (IGF1) is a hormone involved in cell proliferation. We previously showed that IGF1 directly stimulates cell proliferation in granulosa cell tumors (GCTs). Estrogen regulates IGF1 expression in several reproductive organs including the uterus and ovaries. This study aimed to investigate the effects of a mixture of endocrine-disrupting chemicals (EDCs) on secretion of IGF1 by COV434 and KGN cells, which have been used as in vitro models of juvenile and adult GCTs, respectively. The EDC mixture contained perfluorooctanoate, perfluorooctane sulfonate, 2,2-dichlorodiphenyldichloroethylene, hexachlorobenzene, and polychlorinated biphenyl 153, which are persistent hormonally active environmental toxicants present in ovarian follicular fluid (FF). Expression and secretion of IGF1 were significantly higher in GTCs than in HGrC1 human non-cancer granulosa cells (with the profile HGrC1 < COV434 < KGN). Treatment with the EDC mixture as well as individual test compounds significantly increased IGF1 secretion in KGN cells. Moreover, IGFBP3 gene expression in KGN cells was downregulated after treatment with the EDC mixtures. The estrogen receptor alpha pathway was involved in this effect. Conditioned medium of KGN cells treated with the EDC mixture increased proliferation of HGrC1 human non-cancer granulosa cells. These results indicate that the mixture of EDCs found in FF increases secretion of IGF1 by KGN cells and thus indirectly contributes to progression of adult GCTs, and increases proliferation of non-cancer granulosa cells.


Subject(s)
Endocrine Disruptors/pharmacology , Follicular Fluid/chemistry , Granulosa Cell Tumor/metabolism , Granulosa Cells/drug effects , Insulin-Like Growth Factor I/metabolism , Ovarian Neoplasms/metabolism , Spheroids, Cellular/drug effects , Adult , Cell Line , Cell Proliferation/drug effects , Female , Granulosa Cells/metabolism , Humans , Insulin-Like Growth Factor I/genetics , PPAR gamma/genetics , Signal Transduction , Spheroids, Cellular/metabolism
3.
Mol Biol Rep ; 46(6): 6325-6338, 2019 Dec.
Article in English | MEDLINE | ID: mdl-31538301

ABSTRACT

Apelin and chemerin are adipocytokines that play important roles in many physiological and pathological processes throughout the body. Our previous study demonstrated that these two adipokines are expressed and secreted by epithelial and granulosa cancer cell lines. 17ß-estradiol (E2) and insulin-like growth factor-1 (IGF-1) are important regulators of ovarian functions, and their roles are well known. This study investigated whether apelin and chemerin regulate proliferation and apoptosis of epithelial (OVCAR-3) and granulosa (COV434) ovarian cancer cell lines by interacting with E2 and IGF-1. Apelin and chemerin did not affect caspase-3 activation in either cell line. However, apelin abrogated the stimulatory effects of E2 on proliferation of OVCAR-3 cells and of IGF-1 on proliferation of COV434 cells independently of ERK1/2 and PI3K via crosstalk of apelin receptor with estrogen receptor alpha and IGF-1 receptor, respectively.


Subject(s)
Apelin/metabolism , Carcinoma, Ovarian Epithelial/metabolism , Estradiol/pharmacology , Granulosa Cell Tumor/metabolism , Insulin-Like Growth Factor I/pharmacology , Ovarian Neoplasms/metabolism , Apelin/genetics , Apelin Receptors/metabolism , Carcinoma, Ovarian Epithelial/genetics , Caspase 3/metabolism , Cell Line, Tumor , Cell Proliferation/drug effects , Chemokines/genetics , Chemokines/metabolism , Estrogen Receptor alpha/metabolism , Female , Gene Expression Regulation, Neoplastic/drug effects , Granulosa Cell Tumor/genetics , Humans , Ovarian Neoplasms/genetics , Receptor, IGF Type 1/metabolism
4.
Chemosphere ; 217: 100-110, 2019 Feb.
Article in English | MEDLINE | ID: mdl-30414542

ABSTRACT

Epidemiological studies have found that women have detectable levels of organic pollutants such as hexachlorobenzene (HCB), 2,2-dichlorodiphenyldichloroethylene (p,p'-DDE), polychlorinated biphenyl 153 (PCB153), perfluorooctanoate (PFOA), and perfluorooctane sulfonate (PFOS) in their follicular fluid. Thus, these compounds may directly affect the function of granulosa cells within the ovary and may promote granulosa cell tumor (GCT) progression. Two human GCT cell lines, COV434 and KGN, have been used as in vitro model systems to represent juvenile (JGCT) and adult (AGCT) GCT subtypes, respectively. In this study, we found that basal expression of estrogen receptor 1 (ESR1), estrogen receptor 2 (ESR2), and insulin-like growth factor 1 receptor (IGF1R) was higher in the AGCT subtype than in the JGCT subtype. All of the compounds acted as mitogenic factors at low nanomolar concentrations in the JGCT and AGCT forms of GCT. Interestingly, PFOA, PFOS, and HCB stimulated cell proliferation through IGF1R, whereas p,p'-DDE acted through GPR30. Moreover, a mixture of the five compounds also significantly stimulated granulosa cell proliferation; however, the observed effect was lower than predicted. Interestingly, the proliferative effect of a mixture of these compounds was dependent on IGF1R and GPR30 but independent of the classic estrogen receptors. Taken together, our results demonstrate for the first time that mixtures of persistent organic pollutants present in follicular fluids may induce granulosa tumor progression through IGF1R and GPR30 by acting as mitogenic factors in granulosa cells.


Subject(s)
Endocrine Disruptors/metabolism , Follicular Fluid/chemistry , Granulosa Cell Tumor/pathology , Receptors, Estrogen/analysis , Receptors, G-Protein-Coupled/physiology , Receptors, Somatomedin/physiology , Adolescent , Adult , Cell Line, Tumor , Cell Proliferation/drug effects , Endocrine Disruptors/pharmacology , Estrogen Receptor alpha/metabolism , Estrogen Receptor beta/metabolism , Female , Granulosa Cell Tumor/etiology , Granulosa Cells/drug effects , Granulosa Cells/pathology , Humans , Mitogens , Ovarian Neoplasms , Receptor, IGF Type 1 , Receptors, Estrogen/metabolism , Receptors, Estrogen/physiology , Young Adult
5.
Toxicol Lett ; 291: 61-69, 2018 Jul.
Article in English | MEDLINE | ID: mdl-29653259

ABSTRACT

Chemerin is an adipocyte-secreted protein that associates with obesity, inflammation, metabolic dysfunction, and carcinogenesis. Previous studies have shown human granulosa cells to produce bioactive chemerin and its receptor CMKLR1. In the present study, we demonstrated that the mRNA level of chemerin receptor is higher in a granulosa cell tumor cell line than in epithelial cancer cells, whereas chemerin expression and secretion were lower. Various exogenous factors, such as bisphenol A and its halogenated derivatives tetrabromobisphenol A and tetrachlorobisphenol A, can affect adipokine expression. For this reason, we investigated the effects of bisphenol A and its derivatives on the expression of chemerin and its receptor. At low nanomolar concentrations, BPA, TBBPA, and TCBPA decreased chemerin expression and secretion only in granulosa cell tumor COV434 cells by both peroxisome proliferator-activated receptor γ and estrogen receptor signaling pathways. Chemerin treatment had no effect on proliferation of ovarian non-cancer and cancer cell lines. However, we also found evidence to support the inhibition of BPA- and TBBPA-induced cell proliferation by chemerin. Taken together, our results indicate for the first time that BPA and its derivatives down-regulate chemerin expression, which can suppress the ability of BPA to induce proliferation. Moreover, both PPARγ and ERs were involved in the BPA-induced decrease in chemerin expression, and its ratio was crucial to exert these effects.


Subject(s)
Benzhydryl Compounds/toxicity , Chemokines/biosynthesis , Chemokines/pharmacology , Intercellular Signaling Peptides and Proteins/biosynthesis , Intercellular Signaling Peptides and Proteins/pharmacology , Ovarian Neoplasms/pathology , Phenols/toxicity , Adipokines/biosynthesis , Cell Line, Tumor , Down-Regulation/drug effects , Female , Granulosa Cell Tumor/metabolism , Humans , PPAR gamma/metabolism , RNA, Messenger/biosynthesis , Receptors, Chemokine/drug effects , Receptors, Chemokine/metabolism , Receptors, Estrogen/drug effects , Receptors, Estrogen/metabolism
6.
Horm Cancer ; 9(3): 166-174, 2018 06.
Article in English | MEDLINE | ID: mdl-29603059

ABSTRACT

The expression of adiponectin receptors AdipoR1 and AdipoR2 has been reported in the human ovary and ovarian cancer tissues. Moreover, adiponectin has been reported to act as an anti-tumor factor by inhibiting cancer cell proliferation. Thus, we investigate whether adiponectin and its receptors influence ovarian cancer development. In the present study, we found that adiponectin was not expressed in the granulosa cell line (COV434), and epithelial ovarian cancer cell lines (OVCAR-3, SKOV-3, and Caov-3). Additionally, we found that AdipoR1 and AdipoR2 expression is lower in epithelial ovarian cancer cells than in granulosa tumor cells. Endogenous 17ß-estradiol as well as exogenous estrogens, such as bisphenol A and its chlorinated and brominated analogs do not affect adiponectin receptor expression. We found that adiponectin inhibited the growth of OVCAR-3 and SKOV-3 cells, and that this effect was independent of apoptosis. Moreover, adiponectin reverses the stimulatory effects of 17ß-estradiol and insulin-like growth factor 1 on cell proliferation by downregulating the expression of their receptors, whereas progesterone increased the sensitivity of cancer cells to adiponectin by upregulating AdipoR1 and AdipoR2 expression. These results suggest interactions between adiponectin and various ovarian steroid hormone and growth factor pathways in ovarian cancer cells.


Subject(s)
Adiponectin/metabolism , Carcinoma, Ovarian Epithelial/metabolism , Epithelial Cells/physiology , Granulosa Cell Tumor/metabolism , Granulosa Cells/physiology , Receptors, Adiponectin/metabolism , Carcinoma, Ovarian Epithelial/genetics , Cell Line, Tumor , Down-Regulation , Estradiol/metabolism , Female , Gene Expression Regulation, Neoplastic , Humans , Insulin-Like Growth Factor I/metabolism , Progesterone/metabolism
7.
Toxicol In Vitro ; 45(Pt 1): 54-59, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28811233

ABSTRACT

Tetrabromobisphenol A (TBBPA) and tetrachlorobisphenol A (TCBPA) are bisphenol A (BPA) analogs, where the phenolic moieties are substituted with halogens (Br or Cl). Previous studies indicate that BPA has significant proliferative effects on in vitro cultured epithelial ovarian cancer (EOC) cells. Considering this, we analyzed the effects of both TBBPA and TCBPA at 1, 10, and 50nM on ovarian cancer cell proliferation. The majority of malignant ovarian tumors are epithelial in origin, but approximately 10% are classified as ovarian sex cord tumors, with the most common type being granulosa cell tumors (GCTs). OVCAR-3 and KGN cells were used as in vitro models to represent EOCs and GCTs, respectively. Here, we found that TBBPA, but not TCBPA, stimulated OVCAR-3 and KGN cell proliferation, with lower potency than BPA. The stimulatory effects of TBBPA and BPA on cell proliferation were reversed by pre-treatment with a G protein-coupled receptor 30 (GPR30) antagonist in both cell lines, which possess similar basal GPR30 expression levels. Taken together, our results show for the first time that TBBPA, which has lower potency than BPA, stimulates ovarian cancer cell proliferation through the GPR30 pathway.


Subject(s)
Chlorophenols/toxicity , Ovarian Neoplasms , Polybrominated Biphenyls/toxicity , Receptors, Estrogen/metabolism , Receptors, G-Protein-Coupled/metabolism , Benzhydryl Compounds/toxicity , Benzodioxoles , Cell Line, Tumor , Cell Proliferation/drug effects , Environmental Pollutants/toxicity , Female , Flame Retardants/toxicity , Gene Expression Regulation/drug effects , Humans , Phenols/toxicity , Quinolines , Receptors, Estrogen/genetics , Receptors, G-Protein-Coupled/genetics
8.
Toxicol Lett ; 269: 15-22, 2017 Mar 05.
Article in English | MEDLINE | ID: mdl-28111160

ABSTRACT

Epidemiological studies have reported that humans have detectable levels of not only bisphenol A (BPA), but also its halogenated derivatives tetrabromobisphenol A (TBBPA) and tetrachlorobisphenol A (TCBPA), in the serum. Our previous study showed that BPA promotes ovarian cancer progression by directly inducing cell proliferation and migration or by indirectly increasing leptin receptor expression, which creates more binding sites for leptin. In this study, we examined the expression of apelin and its receptor in non-cancer and cancer cell lines derived from the human ovary, and further explored whether the expression of apelin and its receptor is modulated by BPA and its derivatives. We found that the apelin receptor expression level was higher in epithelial cancer cells than in granulosa tumour cells, whereas the reverse was true for apelin expression and secretion. BPA, TBBPA and TCBPA at low nanomolar concentrations increased apelin expression and secretion in the epithelial ovarian cancer cell line OVCAR-3, which involved the peroxisome proliferator-activated receptor γ but not oestrogen receptors. We also found evidence that secreted apelin acts as a mitogenic factor in OVCAR-3 cells, and that BPA intensifies its activity. Taken together, our results suggest that BPA and its derivatives induce ovarian cancer cell progression by up-regulating apelin, which acts as a mitogenic factor in these cells.


Subject(s)
Benzhydryl Compounds/toxicity , Chlorophenols/toxicity , Gene Expression Regulation, Neoplastic , Intercellular Signaling Peptides and Proteins/metabolism , Neoplasms, Glandular and Epithelial/genetics , Ovarian Neoplasms/genetics , Phenols/toxicity , Polybrominated Biphenyls/toxicity , Apelin , Carcinoma, Ovarian Epithelial , Cell Line, Tumor , Cell Proliferation/drug effects , Female , Humans , Intercellular Signaling Peptides and Proteins/genetics , PPAR gamma/genetics , PPAR gamma/metabolism , Receptors, Estrogen/genetics , Receptors, Estrogen/metabolism , Receptors, Leptin/genetics , Receptors, Leptin/metabolism , Up-Regulation
9.
Reprod Sci ; 23(11): 1600-1608, 2016 11.
Article in English | MEDLINE | ID: mdl-27255147

ABSTRACT

Accumulating evidence suggests that leptin is expressed at higher levels in obese women and stimulates cell migration in epithelial cancers. However, the biology of ovarian cancer is different from others, mainly due to the production of estrogens because of the involvement of ovarian tissue, which is the main source of estrogens; as a result, the levels are at least 100- to 1000-fold higher than normal circulating levels. Thus, ovarian cancer tissues are exposed to 17ß-estradiol, which promotes ovarian cancer cell migration and may modulate the effect of other hormones. Therefore, this study investigated the effects of 17ß-estradiol (1 nmol/L) with leptin (1-40 ng/mL) at physiological levels, on the migration of OVCAR-3 and SKOV-3 ovarian cancer cells, and the expression levels and activity of metalloproteinases (MMPs) 2 and 9. Here, we found that leptin stimulated ovarian cancer cell line migration, which is mediated via the expression and activity of MMP-9 in the OVCAR-3 but not in the SKOV-3 cells. After the administration of 17ß-estradiol and leptin, we observed antagonistic effects of 17ß-estradiol on leptin-induced OVCAR-3 cell migration and MMP-9 expression and activity. Moreover, the antagonistic effect of 17ß-estradiol on leptin-induced cancer cell migration was reversed by pretreatment of the cells with the phosphatidylinositol 3-kinase (PI3K) pathway inhibitor. Taken together, our results, for the first time, show that in ovarian cancer cells ObR+/ER+, 17ß-estradiol has an antagonistic effect on leptin-induced cell migration as well as MMP-9 expression and activity, which is mediated by the PI3K pathway.


Subject(s)
Cell Movement/drug effects , Estradiol/pharmacology , Leptin/pharmacology , MAP Kinase Signaling System/drug effects , Ovarian Neoplasms/metabolism , Cell Line, Tumor , Estradiol/physiology , Female , Humans , Leptin/physiology , Matrix Metalloproteinase 2 , Matrix Metalloproteinase 9 , Ovarian Neoplasms/chemically induced , Phosphatidylinositol 3-Kinases/metabolism , Proto-Oncogene Proteins c-akt/metabolism , RNA, Messenger/metabolism , STAT3 Transcription Factor/metabolism
10.
Toxicol Lett ; 229(2): 357-65, 2014 Sep 02.
Article in English | MEDLINE | ID: mdl-24997338

ABSTRACT

Bisphenol A (BPA), is present in a multitude of products, including food and water containers, food can linings, dentistry sealants, and thermal paper. BPA can induce the growth of human ovarian cancer cell lines. Reduction of adhesion and the initiation of metastasis are important events in cancer progression; therefore, this study investigated the effects of BPA (0.1-100nM) on the migration of OVCAR-3 ovarian cancer cells and the expression levels of metalloproteinases (MMPs) and cadherins. The oestrogenic compound 17ß-estradiol (40nM) was used as a positive control for estrogenic properties of bisphenol A. BPA stimulated cell migration, and the effect of BPA was similar to that of 17ß-estradiol. BPA-induced cell migration was accompanied by up-regulation of the migration-related factors MMP-2, MMP-9 and N-cadherin, but E-cadherin expression and activity was unaffected. The stimulatory effects of BPA on cell migration were abolished by pre-treatment of the cells with inhibitors of the mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase pathways (PI3K). In conclusion, the results presented here show that BPA induces OVCAR-3 cells migration by activating MAPK and PI3K/Akt signalling pathways.


Subject(s)
Benzhydryl Compounds/toxicity , Carcinogens/toxicity , Cell Movement/drug effects , MAP Kinase Kinase 2/drug effects , Ovarian Neoplasms/diagnosis , Phenols/toxicity , Phosphatidylinositol 3-Kinases/drug effects , Proto-Oncogene Proteins c-akt/drug effects , Signal Transduction/drug effects , Benzhydryl Compounds/pharmacology , Blotting, Western , Carcinogens/pharmacology , Cell Line, Tumor , Female , Humans , Matrix Metalloproteinase 2/metabolism , Matrix Metalloproteinase 9/metabolism , Phenols/pharmacology , Real-Time Polymerase Chain Reaction
12.
Rev. Soc. Bras. Med. Trop ; 36(5): 633-634, set.-out. 2003.
Article in English | LILACS | ID: lil-348039

ABSTRACT

The present communication reports the presence of Lutzomyia longipalpis in Corumbá, Mato Grosso do Sul, where the principal vector is Lutzomyia cruzi


Subject(s)
Animals , Insect Vectors , Leishmaniasis, Visceral , Psychodidae , Brazil
SELECTION OF CITATIONS
SEARCH DETAIL